Endocrinology, Vol 125, 1484-1491, Copyright © 1989 by Endocrine Society

ARTICLES

Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture

TA Linkhart and S Mohan
Department of Biochemistry, Loma Linda University School of Medicine, Veterans' Hospital, Loma Linda, California 92357.

Effects of increased bone resorption on release of insulin-like growth factor-I (IGF-I) and IGF-II into the osteoblast microenvironment were investigated using neonatal mouse calvaria organ cultures. Release of these growth factors from calvaria into serum-free medium was quantitated using a human IGF-I RIA and human IGF-II RRA. Untreated calvaria released several-fold more IGF-II than IGF-I. PTH (from 1-12 nM) stimulated a dose-dependent increase in the release of both growth factors that correlated with increased calcium release and was sustained for up to 6 days. IGF-I and IGF-II release were maximally stimulated 5- to 10-fold and 1.5- to 2-fold, respectively, compared to untreated control values. Calcitonin inhibited PTH-stimulated resorption, but had no effect on PTH stimulation of IGF-I and IGF-II release, suggesting that PTH effects on IGF-I and IGF-II release were not dependent on resorption. Furthermore, the amounts of IGF-I and IGF- II released from calvaria during 6 days of culture were 5-fold more than the amounts of IGF-I and IGF-II present in the calvaria (bone plus cells) at the beginning of culture, suggesting that much of the IGF-I and IGF-II released was newly produced by calvaria cells. The results suggest that PTH directly stimulated calvarial osteoblasts to release IGF-I and IGF-II. Since IGF-I and IGF-II stimulate osteoblastic cell proliferation, the effect of PTH on the release of these and other growth factors may mediate coupling of bone formation to bone resorption.

This article has been cited by other articles:

				T. Tobimatsu, H. Kaji, H. Sowa, J. Naito, L. Canaff, G. N. Hendy, T. Sugimoto, and K. Chihara Parathyroid Hormone Increases {beta}-Catenin Levels through Smad3 in Mouse Osteoblastic Cells Endocrinology, May 1, 2006; 147(5): 2583 - 2590. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, M. F. Iu, T. Tsukamoto, T. Sugimoto, and K. Chihara Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts J. Biol. Chem., December 26, 2003; 278(52): 52240 - 52252. [Abstract] [Full Text] [PDF]

				S.P. Barros, M.A.D. Silva, M.J. Somerman, and F.H. Nociti Jr. Parathyroid Hormone Protects against Periodontitis-associated Bone Loss J. Dent. Res., October 1, 2003; 82(10): 791 - 795. [Abstract] [Full Text] [PDF]

				R. Chiusaroli, A. Maier, M. C. Knight, M. Byrne, L. M. Calvi, R. Baron, S. M. Krane, and E. Schipani Collagenase Cleavage of Type I Collagen Is Essential for Both Basal and Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor-Induced Osteoclast Activation and Has Differential Effects on Discrete Bone Compartments Endocrinology, September 1, 2003; 144(9): 4106 - 4116. [Abstract] [Full Text] [PDF]

				F. K. W. Chan, S.-C. Tiu, K.-L. Choi, C.-H. Choi, A. P. S. Kong, and C.-C. Shek Increased Bone Mineral Density in Patients with Chronic Hypoparathyroidism J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3155 - 3159. [Abstract] [Full Text] [PDF]

				M. T. Goodman, A. H. Wu, K.-H. Tung, K. McDuffie, L. N. Kolonel, A. M. Y. Nomura, K. Terada, L. R. Wilkens, S. Murphy, and J. H. Hankin Association of Dairy Products, Lactose, and Calcium with the Risk of Ovarian Cancer Am. J. Epidemiol., July 15, 2002; 156(2): 148 - 157. [Abstract] [Full Text] [PDF]

				N. Miyakoshi, Y. Kasukawa, T. A. Linkhart, D. J. Baylink, and S. Mohan Evidence That Anabolic Effects of PTH on Bone Require IGF-I in Growing Mice Endocrinology, October 1, 2001; 142(10): 4349 - 4356. [Abstract] [Full Text] [PDF]

				C. J. Rosen and J. P. Bilezikian Anabolic Therapy for Osteoporosis J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 957 - 964. [Abstract] [Full Text]

				P. J. Kaplan, S. Mohan, P. Cohen, B. A. Foster, and N. M. Greenberg The Insulin-like Growth Factor Axis and Prostate Cancer: Lessons from the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model Cancer Res., May 1, 1999; 59(9): 2203 - 2209. [Abstract] [Full Text] [PDF]

				S. Rihani-Bisharat, G. Maor, and D. Lewinson In Vivo Anabolic Effects of Parathyroid Hormone (PTH) 28-48 and N-Terminal Fragments of PTH and PTH-Related Protein on Neonatal Mouse Bones Endocrinology, March 1, 1998; 139(3): 974 - 981. [Abstract] [Full Text] [PDF]

				S. B. TRIPPEL, R. D. COUTTS, T. A. EINHORN, G. R. MUNDY, and R. G. ROSENFELD Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*{{dagger}} J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1272 - 86. [Full Text]